Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

LAMA2-related myopathy; frequency among congenital and limb-girdle muscular dystrophies

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{1e49955e52924fa9b4714669a4b61fd4,
title = "LAMA2-related myopathy; frequency among congenital and limb-girdle muscular dystrophies",
abstract = "Introduction: Muscular dystrophy caused by LAMA2-gene mutations is an autosomal recessive disease typically presenting as a severe, early-onset congenital muscular dystrophy (CMD). However, milder cases with a limb-girdle type muscular dystrophy (LGMD) have been described. Methods: In this study, we assessed the frequency and phenotypic spectrum of LAMA2-related muscular dystrophy in cohorts of CMD (n=18) and LGMD2 (n=128) identified in the last 15 years in eastern Denmark. The medical history, brain-MRI, muscle pathology, muscle laminin-α2 expression, and genetic analyses were assessed. Results: Molecular genetics revealed 2 pathogenic LAMA2 mutations in 5/18 CMD and 3/128 LGMD patients, corresponding to a LAMA2-mutation frequency of 28% in the CMD and 2.3% in the LGMD cohorts, respectively. Discussion: This study demonstrates a wide clinical spectrum of LAMA2-related muscular dystrophy and its prevalence in an LGMD2 cohort, which indicates that LAMA2 muscular dystrophy should be included in the LGMD2 nomenclature. This article is protected by copyright. All rights reserved.",
author = "Nicoline L{\o}kken and Born, {Alfred Peter} and Morten Duno and John Vissing",
note = "Copyright {\textcopyright} 2015 Wiley Periodicals, Inc., a Wiley company.",
year = "2015",
month = feb,
day = "5",
doi = "10.1002/mus.24588",
language = "English",
pages = "547--553",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John/Wiley & Sons, Inc. John/Wiley & Sons Ltd",

}

RIS

TY - JOUR

T1 - LAMA2-related myopathy; frequency among congenital and limb-girdle muscular dystrophies

AU - Løkken, Nicoline

AU - Born, Alfred Peter

AU - Duno, Morten

AU - Vissing, John

N1 - Copyright © 2015 Wiley Periodicals, Inc., a Wiley company.

PY - 2015/2/5

Y1 - 2015/2/5

N2 - Introduction: Muscular dystrophy caused by LAMA2-gene mutations is an autosomal recessive disease typically presenting as a severe, early-onset congenital muscular dystrophy (CMD). However, milder cases with a limb-girdle type muscular dystrophy (LGMD) have been described. Methods: In this study, we assessed the frequency and phenotypic spectrum of LAMA2-related muscular dystrophy in cohorts of CMD (n=18) and LGMD2 (n=128) identified in the last 15 years in eastern Denmark. The medical history, brain-MRI, muscle pathology, muscle laminin-α2 expression, and genetic analyses were assessed. Results: Molecular genetics revealed 2 pathogenic LAMA2 mutations in 5/18 CMD and 3/128 LGMD patients, corresponding to a LAMA2-mutation frequency of 28% in the CMD and 2.3% in the LGMD cohorts, respectively. Discussion: This study demonstrates a wide clinical spectrum of LAMA2-related muscular dystrophy and its prevalence in an LGMD2 cohort, which indicates that LAMA2 muscular dystrophy should be included in the LGMD2 nomenclature. This article is protected by copyright. All rights reserved.

AB - Introduction: Muscular dystrophy caused by LAMA2-gene mutations is an autosomal recessive disease typically presenting as a severe, early-onset congenital muscular dystrophy (CMD). However, milder cases with a limb-girdle type muscular dystrophy (LGMD) have been described. Methods: In this study, we assessed the frequency and phenotypic spectrum of LAMA2-related muscular dystrophy in cohorts of CMD (n=18) and LGMD2 (n=128) identified in the last 15 years in eastern Denmark. The medical history, brain-MRI, muscle pathology, muscle laminin-α2 expression, and genetic analyses were assessed. Results: Molecular genetics revealed 2 pathogenic LAMA2 mutations in 5/18 CMD and 3/128 LGMD patients, corresponding to a LAMA2-mutation frequency of 28% in the CMD and 2.3% in the LGMD cohorts, respectively. Discussion: This study demonstrates a wide clinical spectrum of LAMA2-related muscular dystrophy and its prevalence in an LGMD2 cohort, which indicates that LAMA2 muscular dystrophy should be included in the LGMD2 nomenclature. This article is protected by copyright. All rights reserved.

U2 - 10.1002/mus.24588

DO - 10.1002/mus.24588

M3 - Journal article

C2 - 25663498

SP - 547

EP - 553

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

ER -

ID: 45042379